RxSight (RXST) reported preliminary Q1 revenue late Wednesday of $37.9 million, up 28% from a year earlier.
Analysts polled by FactSet expect $39.6 million .
The company also lowered its 2025 revenue guidance range to between $160 million and $175 million, down from its previous projection of $185 million to $197 million.
Analysts surveyed by FactSet expect $187.8 million.